MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sims, C.
Right arrow Articles by Harvey, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sims, C.
Right arrow Articles by Harvey, R. D.

Vol. 58, Issue 6, 1213-1221, December 2000

Tyrosine Phosphatase Inhibitors Selectively Antagonize beta -Adrenergic Receptor-Dependent Regulation of Cardiac Ion Channels

Carl Sims, Jason Chiu, and Robert D. Harvey

Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio

beta -Adrenergic receptor stimulation regulates the activity of several different cardiac ion channels through an adenylate cyclase/cAMP/protein kinase A-dependent mechanism. Previous work has suggested that basal tyrosine kinase activity attenuates the beta -adrenergic responsiveness of these cardiac ion channels, supporting the idea that tyrosine phosphorylation exerts an inhibitory effect at some point in the common signaling pathway. To determine which element in the beta -adrenergic pathway is regulated by tyrosine kinase activity, we studied the effects of various protein tyrosine phosphatase (PTP) inhibitors on the cAMP-dependent regulation of the L-type Ca2+ current in guinea pig ventricular myocytes. Three such compounds, sodium orthovanadate, peroxovanadate, and bpV(phen), had no effect on the basal Ca2+ current, yet each caused a pronounced inhibition of the Ca2+ current stimulated by the beta -adrenergic receptor agonist isoproterenol. These observations are consistent with the idea that basal tyrosine kinase activity is capable of inhibiting beta -adrenergic responses. However, these PTP inhibitors had no effect on cAMP-dependent stimulation of the Ca2+ current via activation of adenylate cyclase with forskolin or activation of H2-histaminergic receptors with histamine. These results are consistent with the idea that inhibition of PTP activity produces an inhibitory effect involving a tyrosine kinase-dependent mechanism acting selectively at the level of the beta -adrenergic receptor. This signaling mechanism does not seem to be linked to tyrosine kinase activity associated with insulin and insulin-like growth factor receptors, because acute exposure to agonists of these receptors did not inhibit isoproterenol regulation of the Ca2+ current.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. Liew, J. K. Williams, P. Collins, and K. T. MacLeod
Soy-Derived Isoflavones Exert Opposing Actions on Guinea Pig Ventricular Myocytes
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 985 - 993.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. E. Belevych, S. Warrier, and R. D. Harvey
Genistein Inhibits Cardiac L-Type Ca2+ Channel Activity by a Tyrosine Kinase-Independent Mechanism
Mol. Pharmacol., September 1, 2002; 62(3): 554 - 565.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. D. Keef, J. R. Hume, and J. Zhong
Regulation of cardiac and smooth muscle Ca2+ channels (CaV1.2a,b) by protein kinases
Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1743 - C1756.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. A. Hirshman, D. Zhu, R. A. Panettieri, and C. W. Emala
Actin depolymerization via the beta -adrenoceptor in airway smooth muscle cells: a novel PKA-independent pathway
Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1468 - C1476.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. P. McLaughlin and C. Chavkin
Tyrosine Phosphorylation of the {micro}-Opioid Receptor Regulates Agonist Intrinsic Efficacy
Mol. Pharmacol., June 1, 2001; 59(6): 1360 - 1368.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics